Pipeline
FluoGuide’s pipeline is under continuous development, yet focused on aggressive brain cancer and lung cancer. However, FluoGuide technology is widely applicable across multiple cancer types.
Pre-clinical
Phase I
Phase II
Phase III
Commercial
FG001
Aggressive Brain cancer
Next milestone: Consolidated plans
Head and Neck cancer
Next milestone: Consolidated plans
Lung cancer
Next milestone: Consolidated plans
Follow-on pipeline
FG002
Next milestone: CTA submission
Photothermal therapy
Next milestone: Plans and timelines
Completed
Ongoing